Cargando…
The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved?
Bax and Bak, two functionally similar, pro-apoptotic proteins of the Bcl-2 family, are known as the gateway to apoptosis because of their requisite roles as effectors of mitochondrial outer membrane permeabilization (MOMP), a major step during mitochondria-dependent apoptosis. The mechanism of how c...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411521/ https://www.ncbi.nlm.nih.gov/pubmed/32802314 http://dx.doi.org/10.12688/f1000research.25607.1 |
_version_ | 1783568398206107648 |
---|---|
author | Luo, Xu O'Neill, Katelyn L. Huang, Kai |
author_facet | Luo, Xu O'Neill, Katelyn L. Huang, Kai |
author_sort | Luo, Xu |
collection | PubMed |
description | Bax and Bak, two functionally similar, pro-apoptotic proteins of the Bcl-2 family, are known as the gateway to apoptosis because of their requisite roles as effectors of mitochondrial outer membrane permeabilization (MOMP), a major step during mitochondria-dependent apoptosis. The mechanism of how cells turn Bax/Bak from inert molecules into fully active and lethal effectors had long been the focal point of a major debate centered around two competing, but not mutually exclusive, models: direct activation and indirect activation. After intensive research efforts for over two decades, it is now widely accepted that to initiate apoptosis, some of the BH3-only proteins, a subclass of the Bcl-2 family, directly engage Bax/Bak to trigger their conformational transformation and activation. However, a series of recent discoveries, using previously unavailable CRISPR-engineered cell systems, challenge the basic premise that undergirds the consensus and provide evidence for a novel and surprisingly simple model of Bax/Bak activation: the membrane (lipids)-mediated spontaneous model. This review will discuss the evidence, rationale, significance, and implications of this new model. |
format | Online Article Text |
id | pubmed-7411521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-74115212020-08-13 The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? Luo, Xu O'Neill, Katelyn L. Huang, Kai F1000Res Review Bax and Bak, two functionally similar, pro-apoptotic proteins of the Bcl-2 family, are known as the gateway to apoptosis because of their requisite roles as effectors of mitochondrial outer membrane permeabilization (MOMP), a major step during mitochondria-dependent apoptosis. The mechanism of how cells turn Bax/Bak from inert molecules into fully active and lethal effectors had long been the focal point of a major debate centered around two competing, but not mutually exclusive, models: direct activation and indirect activation. After intensive research efforts for over two decades, it is now widely accepted that to initiate apoptosis, some of the BH3-only proteins, a subclass of the Bcl-2 family, directly engage Bax/Bak to trigger their conformational transformation and activation. However, a series of recent discoveries, using previously unavailable CRISPR-engineered cell systems, challenge the basic premise that undergirds the consensus and provide evidence for a novel and surprisingly simple model of Bax/Bak activation: the membrane (lipids)-mediated spontaneous model. This review will discuss the evidence, rationale, significance, and implications of this new model. F1000 Research Limited 2020-08-06 /pmc/articles/PMC7411521/ /pubmed/32802314 http://dx.doi.org/10.12688/f1000research.25607.1 Text en Copyright: © 2020 Luo X et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Luo, Xu O'Neill, Katelyn L. Huang, Kai The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? |
title | The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? |
title_full | The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? |
title_fullStr | The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? |
title_full_unstemmed | The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? |
title_short | The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? |
title_sort | third model of bax/bak activation: a bcl-2 family feud finally resolved? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411521/ https://www.ncbi.nlm.nih.gov/pubmed/32802314 http://dx.doi.org/10.12688/f1000research.25607.1 |
work_keys_str_mv | AT luoxu thethirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved AT oneillkatelynl thethirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved AT huangkai thethirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved AT luoxu thirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved AT oneillkatelynl thirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved AT huangkai thirdmodelofbaxbakactivationabcl2familyfeudfinallyresolved |